Haw Par Corporation (H02.SI) Stock Price
Haw Par Corporation Price
Over the last 19 years Haw Par Corporation grew revenue by 3.5% annually, reaching 229.97 M SGD. Earnings per share have grown at 5.1% per year over the last 19 years. For Haw Par Corporation, the net margin of 115.4% is up versus 78.0% a few years ago. At today's price the dividend yield works out to roughly 3.10%. The payout ratio is around 33% of earnings. The dividend has grown at 4.5% per year over the past 19 years.
Haw Par Corporation stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Haw Par Corporation business model & stock analysis
Frequently asked questions about Haw Par Corporation
The business model of Haw Par Corporation Ltd revolves around its diverse portfolio of healthcare and leisure businesses. Haw Par's healthcare business includes the manufacturing and distribution of traditional topical analgesic products, such as Tiger Balm, which are widely recognized for their effectiveness in pain relief. Additionally, the company operates clinics and nursing homes in Singapore and Malaysia. In the leisure sector, Haw Par owns and manages a renowned theme park called "Underwater World Singapore". Through its business model, Haw Par Corporation Ltd aims to provide quality healthcare products and services, while also offering unique leisure experiences to its customers.
Haw Par Corporation Ltd is primarily active in the healthcare and leisure industries.
The main competitors of Haw Par Corporation Ltd in the market include companies like Tiger Balm, Mentholatum, and VapoRub.
Haw Par Corporation Ltd, a renowned company, has a rich history and background. Founded in 1969, it originated as a trading business in Singapore. The company is primarily engaged in healthcare, leisure, and property activities. Haw Par Corporation Ltd gained significant recognition through the Tiger Balm brand, known for its quality healthcare products worldwide. Over the years, the company diversified its portfolio, expanding into property investments and development. Today, Haw Par Corporation Ltd's continued success is driven by its commitment to providing innovative solutions in healthcare and leisure sectors, while maintaining a strong focus on sustainable growth strategies.
Haw Par Corporation Ltd has achieved significant milestones throughout its history. The company successfully expanded its business beyond its initial pharmaceutical roots and established itself as a diversified conglomerate. Haw Par Corporation Ltd's key achievements include the development and expansion of its globally recognized Tiger Balm brand, contributing to its strong market position in the healthcare industry. Additionally, the company has made strategic investments in other sectors, such as property development and leisure businesses, contributing to its overall growth and profitability. Haw Par Corporation Ltd continues to thrive through its commitment to innovation, quality, and business excellence.
Haw Par Corporation Ltd, a renowned Singapore-based company, is primarily present in various countries and regions. The company has a significant presence in Singapore, where it is headquartered. Additionally, Haw Par Corporation Ltd has expanded its operations to other key markets such as Malaysia, United Kingdom, China, and the United States. With diverse business interests ranging from healthcare and leisure products to property investments, Haw Par Corporation Ltd has built a global footprint and continues to explore opportunities in different regions worldwide.
Haw Par Corporation Ltd is a renowned company with strong values and a distinctive corporate philosophy. The company believes in integrity, transparency, and accountability in all its operations. Haw Par values innovation and strives for excellence in its products and services. With a commitment to providing high-quality healthcare and wellness products, Haw Par emphasizes consumer trust and satisfaction. The company's corporate philosophy centers around putting customers first, maintaining strong corporate governance, and creating long-term value for its stakeholders. Haw Par Corporation Ltd truly embodies its values and corporate philosophy, making it a reliable and reputable choice for investors and consumers alike.
Converted at the current exchange rate, the Haw Par Corporation share trades at 9.04 EUR (12.92 SGD).
The Haw Par Corporation share (H02.SI) is listed on 3 stock exchanges, including: SGX (Singapur) (H02.SI).
The Haw Par Corporation Ltd is a Singapore-based company that operates in various industries including healthcare, leisure, and real estate. It was founded in 1969 and has since established a strong presence in Asia. The company specializes in healthcare, owning and operating the Tiger Balm Garden which is renowned for its herbal and natural remedies. It also offers other health products such as cold medicine, cough drops, and sore throat lozenges under the brand name "Kwan Loong". Additionally, the company owns and operates Ren Ci Hospital, one of the largest private clinics in Singapore specializing in elderly care and charitable services. In the leisure sector, the company operates the Underwater World Singapore, one of the largest aquariums in Asia, as well as the famous Haw Par Villa theme park known for its Chinese mythology statues and sculptures. In the real estate industry, the company focuses on property development and sales, particularly in luxury residential and condominium projects in Asia. It also engages in the rental of commercial spaces and operates multipurpose buildings in various parts of Singapore. In summary, the Haw Par Corporation Ltd is a diversified company catering to a wide and global audience. Its business model is centered around providing high-quality products and services tailored to the needs of its customers. Through its presence in various industries, the company is able to take on more risks and utilize the benefits of diversification.
The expected revenue of Haw Par Corporation is 216.72 M SGD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Haw Par Corporation is 224.89 M SGD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Haw Par Corporation is currently 12.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Haw Par Corporation stock.
The price-to-sales ratio (P/S) of Haw Par Corporation is currently 13.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Haw Par Corporation stock.
The Eulerpool Quality Score for Haw Par Corporation is 4/10.
The ISIN of Haw Par Corporation is SG1D25001158. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Haw Par Corporation is 862742. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Haw Par Corporation is H02.SI. The ticker symbol is used to trade Haw Par Corporation shares on the stock exchange.
Haw Par Corporation stock
Haw Par Corporation Peer Group
Haw Par Corporation Ticker
Haw Par Corporation FIGI
All fundamentals and in-depth analysis of Haw Par Corporation
Our stock analysis for Haw Par Corporation stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haw Par Corporation. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.